E-LIB Suche - Ergebnisse für: Roghmann, F

1

Why underrepresentation costs lives: First results from a h..:

Rieger, C. ; Hübers, M. ; Pfister, D....
European Urology. 85 (2024) - p. S160-S161 , 2024

Link: https://doi.org/10.1016/..

2

Loss of membranous NECTIN-4 occurs frequently during metast..:

Klümper, N. ; Ralser, D.J. ; Ellinger, J....
European Urology. 83 (2023) - p. S772-S773 , 2023

Link: https://doi.org/10.1016/..

3

Intrinsic molecular urothelial cancer subtypes remain stabl..:

Cox, A. ; Klümper, N. ; Stein, J....
European Urology. 83 (2023) - p. S1690-S1691 , 2023

Link: https://doi.org/10.1016/..

4

Spatial immunephenotypes of distant metastases but not matc..:

Erlmeier, F. ; Klümper, N. ; Landgraf, L....
European Urology. 83 (2023) - p. S1686-S1687 , 2023

Link: https://doi.org/10.1016/..

5

Oncological and safety profiles in patients undergoing simu..:

Laukhtina, E. ; Moschini, M. ; Krajewski, W....
European Urology. 81 (2022) - p. S378-S379 , 2022

Link: https://doi.org/10.1016/..

6

Randomisierte kontrollierte multizentrische Studie zur Albu..:

Sakr, Yasser ; Gattinoni, Luciano ; Schulze, C....
Der Anaesthesist. 70 (2021) 6 - p. 528-530 , 2021

Link: https://doi.org/10.1007/..

7

Indikationen und Technik der Frühzystektomie:

Roghmann, F. ; Mayr, R. ; Tully, K....
Der Urologe. 60 (2021) 11 - p. 1424-1431 , 2021

Link: https://doi.org/10.1007/..

8

Selecting the best candidates for cisplatin-based adjuvant ..:

Afferi, L. ; Lonati, C. ; Montorsi, F....
European Urology Open Science. 33 (2021) - p. S365-S367 , 2021

Link: https://doi.org/10.1016/..

9

Selecting the best candidates for cisplatin-based adjuvant ..:

Afferi, L. ; Lonati, C. ; Montorsi, F....
European Urology Open Science. 32 (2021) - p. S82 , 2021

Link: https://doi.org/10.1016/..

10

Selecting the best candidates for platinum-based adjuvant c..:

Afferi, L. ; Lonati, C. ; Montorsi, F....
European Urology. 79 (2021) - p. S1115-S1116 , 2021

Link: https://doi.org/10.1016/..

11

Qualitätsparameter bei der radikalen Zystektomie – Chancen,..:

Bladder Cancer Research Initiative for Drug Targets Germany (BRIDGE) Consortium e. V. ; Roghmann, F. ; Breyer, J....
Der Urologe. 60 (2021) 2 - p. 151-161 , 2021

Link: https://doi.org/10.1007/..

12

A randomized, double-blind, placebo-controlled, phase 3 tri..:

Schnabel, M.J. ; Pal, S.K. ; Valderrama, B.P....
European Urology Open Science. 33 (2021) - p. S370-S371 , 2021

Link: https://doi.org/10.1016/..

13

Impact of residual microscopial evidence of prostate cancer..:

Tully, K.H. ; Schulmeyer, M. ; Reike, M....
European Urology Open Science. 19 (2020) - p. e1778 , 2020

Link: https://doi.org/10.1016/..

14

Adjuvant chemotherapy is ineffective in patients with bladd..:

Zamboni, S. ; Baumeister, P. ; Aziz, A....
European Urology Open Science. 19 (2020) - p. e1586-e1587 , 2020

Link: https://doi.org/10.1016/..

15

Prognostic role of FGFR alterations and FGFR mRNA expressio..:

Roghmann, F. ; Wirtz, R. ; Santiago-Walker, A....
European Urology Open Science. 19 (2020) - p. e830 , 2020

Link: https://doi.org/10.1016/..